510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0196-2018Class II

TrypticaseTM Soy Agar with 5% Sheep Blood (TSA IITM), Catalog Number 221261 Trypticase Soy Agar with 5% or...

Becton Dickinson & Co / initiated 2017-05-22 / Terminated / root cause: manufacturing process

Becton Dickinson & Co. began a recall of TrypticaseTM Soy Agar with 5% Sheep Blood (TSA IITM), Catalog Number 221261 Trypticase Soy Agar with 5% or 10% Sheep Blood is used for cultivating fastidious... on . FDA classified it as Class II and gives the reason as "Listeria monocytogenes contamination of non-sterile plated media". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0196-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
TrypticaseTM Soy Agar with 5% Sheep Blood (TSA IITM), Catalog Number 221261 Trypticase Soy Agar with 5% or 10% Sheep Blood is used for cultivating fastidious microorganisms and for the visualization of hemolytic reactions produced by many bacterial species.
Product code
JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
Reason for recall
Listeria monocytogenes contamination of non-sterile plated media
Root cause tag
manufacturing process
FDA root cause
Material/Component Contamination
Action
BD Life Sciences initiated communication with distributors by issuing Urgent Product Recall and Customer Response Form notices via UPS mailing on May 22, 2017. General customers were issued Urgent Product Recall and Customer Response Form letters via UPS mailing on May 25, 2017. - General customers were advised to visually inspect all non-sterile prepared media prior to use to assure that there is no surface and/or subsurface contamination. If the customer observes a plate without evidence of microbial contamination that grows Listeria, please consult the clinician to make sure this result is consistent with the patient's clinical presentation. - Distributors were advised to discontinue distribution of the lots and to discard any remaining inventory. Customers are advised to complete and return the enclosed response form to: Attention: Regulatory Compliance, Fax: 410-316-4258 or email to [email protected] **Note to Distributors: Please provide BD Regulatory Compliance an Excel file or a list with name, address and telephone number of end-users who were shipped this product from their distribution branches so they can be notified. Mail or fax to: BD Regulatory Compliance 7 Loveton Circle Mail Stop 640, Sparks, MD 21152 Fax: 410-316-4258; Email: [email protected]. Customers with questions please contact BD Support at 1-800-638-8663. For customers outside of the U.S., contact your local BD representative or distributor. For questions regarding this recall call 410-316-4000.
Quantity in commerce
250, 300 plates
Distribution
Worldwide Distribution - US including AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, FA, HI, IA, IS, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT & WA; International - Canada, Guam and Japan
Product codes and lots
Lot Number: 7032978 - Exp Date May 24, 2017  7048902 - Exp Date June 9, 2017

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0196-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0196-2018Class IITerminatedVoluntary: Firm initiated